Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

A novel heterozygous ABCB4, RUNDC3B and ABCB1 deletion associated with severe cholestatic liver disease in adulthood.

Terziroli Beretta-Piccoli B, Thompson R, Foskett P, Cerny A, Merlo E, Vergani D, Rougemont AL, Moix I, Mieli-Vergani G, Morris M.

Hepatology. 2019 May 24. doi: 10.1002/hep.30783. [Epub ahead of print]

PMID:
31127640
2.

Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents.

Terziroli Beretta-Piccoli B, Di Bartolomeo C, Deleonardi G, Grondona AG, Silvestri T, Tesei C, Melidona L, Cerny A, Mertens J, Semmo N, Semela D, Moradpour D, Mieli-Vergani G, Vergani D, Muratori L; Swiss Hepatitis C Cohort Study.

J Autoimmun. 2019 Apr 29. pii: S0896-8411(19)30186-6. doi: 10.1016/j.jaut.2019.04.019. [Epub ahead of print]

PMID:
31047768
3.

A method for determination of one hundred endogenous steroids in human serum by gas chromatography-tandem mass spectrometry.

Hill M, Hána V Jr, Velíková M, Pařízek A, Kolátorová L, Vítků J, Škodová T, Šimková M, Šimják P, Kancheva R, Koucký M, Kokrdová Z, Adamcová K, Černý A, Hájek Z, Dušková M, Bulant J, Stárka L.

Physiol Res. 2019 Apr 30;68(2):179-207.

4.

Controlling HCV in Switzerland: running against the clock.

Cerny A, Blindenbacher R, Moriggia A.

Swiss Med Wkly. 2019 Mar 24;149:w20005. doi: 10.4414/smw.2019.20005. eCollection 2019 Mar 11. No abstract available.

5.

May circulating steroids reveal a predisposition to intrahepatic cholestasis of pregnancy in non-pregnant women?

Šimják P, Hill M, Pařízek A, Vítek L, Velíková M, Dušková M, Kancheva R, Bulant J, Koucký M, Kokrdová Z, Adamcová K, Černý A, Hájek Z, Stárka L.

Physiol Res. 2018 Nov 28;67(Supplementum 3):S499-S510.

6.

Autoimmune liver disease serology in acute hepatitis E virus infection.

Terziroli Beretta-Piccoli B, Ripellino P, Gobbi C, Cerny A, Baserga A, Di Bartolomeo C, Bihl F, Deleonardi G, Melidona L, Grondona AG, Mieli-Vergani G, Vergani D, Muratori L; Swiss Autoimmune Hepatitis Cohort Study Group.

J Autoimmun. 2018 Nov;94:1-6. doi: 10.1016/j.jaut.2018.07.006. Epub 2018 Jul 7.

PMID:
30336842
7.

Low maternal serum concentrations of mannose-binding lectin are associated with the risk of shorter duration of pregnancy and lower birthweight.

Koucký M, Malíčková K, Kopřivová H, Cindrová-Davies T, Hrbáčková H, Černý A, Šimják P, Pařízek A, Zima T.

Scand J Immunol. 2018 Jul;88(1):e12675. doi: 10.1111/sji.12675.

PMID:
29758096
8.

[The role of T-regulatory lymphocytes in pathogenesis of preterm delivery].

Hrbáčková H, Koucký M, Malíčková K, Černý A, Gáborová E, Kopřivová H, Hinďoš M.

Ceska Gynekol. Winter 2017;82(6):487-490. Czech.

PMID:
29302984
9.

Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.

Terziroli Beretta-Piccoli B, Stirnimann G, Cerny A, Semela D, Hessler R, Helbling B, Stickel F, Kalid-de Bakker C, Bihl F, Giostra E, Filipowicz Sinnreich M, Oneta C, Baserga A, Invernizzi P, Carbone M, Mertens J.

Clin Rev Allergy Immunol. 2018 Apr;54(2):295-306. doi: 10.1007/s12016-017-8656-x.

PMID:
29181702
10.

[The role of maternal imunity and woman´s microbiome in the pathogenesis of preterm labor].

Koucký M, Malíčková K, Hrdý J, Černý A, Hrbáčková H, Šimják P, Pařízek A.

Ceska Gynekol. Fall 2017;82(5):407-410. Czech.

PMID:
29020789
11.

Hepatitis.

Cerny A.

Ther Umsch. 2017 Jul;74(3):77. doi: 10.1024/0040-5930/a000888. German. No abstract available.

PMID:
28777045
12.

Detection of Nocturnal Scratching Movements in Patients with Atopic Dermatitis Using Accelerometers and Recurrent Neural Networks.

Moreau A, Anderer P, Ross M, Cerny A, Almazan TH, Peterson B, Moreau A, Anderer P, Ross M, Cerny A, Almazan TH, Peterson B.

IEEE J Biomed Health Inform. 2018 Jul;22(4):1011-1018. doi: 10.1109/JBHI.2017.2710798. Epub 2017 Jun 8.

PMID:
28613187
13.

A systematic review and meta-analysis of HCV clearance.

Gauthiez E, Habfast-Robertson I, Rüeger S, Kutalik Z, Aubert V, Berg T, Cerny A, Gorgievski M, George J, Heim MH, Malinverni R, Moradpour D, Müllhaupt B, Negro F, Semela D, Semmo N, Villard J, Bibert S, Bochud PY; Swiss Hepatitis C Cohort Study.

Liver Int. 2017 Oct;37(10):1431-1445. doi: 10.1111/liv.13401. Epub 2017 Mar 30. Review.

PMID:
28261910
14.

A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.

Ulveling D, Le Clerc S, Cobat A, Labib T, Noirel J, Laville V, Coulonges C, Carpentier W, Nalpas B, Heim MH, Poynard T, Cerny A, Pol S, Bochud PY, Dabis F, Theodorou I, Lévy Y, Salmon D, Abel L, Dominguez S, Zagury JF; HEPAVIH ANRS CO13 Cohort Study Group; Swiss Hepatitis C Cohort Study Group; French ANRS HC EP 26 Genoscan Study Group.

Hepatology. 2016 Nov;64(5):1462-1472. doi: 10.1002/hep.28695. Epub 2016 Jul 29.

PMID:
27339598
15.

A Comprehensive Evaluation of Steroid Metabolism in Women with Intrahepatic Cholestasis of Pregnancy.

Pařízek A, Hill M, Dušková M, Vítek L, Velíková M, Kancheva R, Šimják P, Koucký M, Kokrdová Z, Adamcová K, Černý A, Hájek Z, Stárka L.

PLoS One. 2016 Aug 5;11(8):e0159203. doi: 10.1371/journal.pone.0159203. eCollection 2016.

16.

 Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.

Parízek A, Simják P, Cerný A, Sestinová A, Zdenková A, Hill M, Dusková M, Vlk R, Kokrdová Z, Koucký M, Vítek L.

Ann Hepatol. 2016 Sep-Oct;15(5):757-61. doi: 10.5604/16652681.1212562.

17.

Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5years of experience.

Slama J, Cerny A, Dusek L, Fischerova D, Zikan M, Kocian R, Germanova A, Cibula D.

Gynecol Oncol. 2016 Sep;142(3):401-4. doi: 10.1016/j.ygyno.2016.07.008. Epub 2016 Jul 7.

PMID:
27396943
18.

A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection.

Tzeng TC, Schattgen S, Monks B, Wang D, Cerny A, Latz E, Fitzgerald K, Golenbock DT.

Cell Rep. 2016 Jul 12;16(2):571-582. doi: 10.1016/j.celrep.2016.06.011. Epub 2016 Jun 23.

19.

Prolonged progesterone administration is associated with less frequent cervicovaginal colonization by Ureaplasma urealyticum during pregnancy - Results of a pilot study.

Koucký M, Malíčková K, Cindrová-Davies T, Smíšek J, Vráblíková H, Černý A, Šimják P, Slováčková M, Pařízek A, Zima T.

J Reprod Immunol. 2016 Aug;116:35-41. doi: 10.1016/j.jri.2016.04.285. Epub 2016 May 4.

PMID:
27172838
20.

Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach.

Giudici F, Bertisch B, Negro F, Stirnimann G, Müllhaupt B, Moradpour D, Cerny A, Keiser O; Swiss Hepatitis C Cohort Study.

J Viral Hepat. 2016 Sep;23(9):697-707. doi: 10.1111/jvh.12535. Epub 2016 Mar 23.

PMID:
27006320
21.

Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.

Parízek A, Šimják P, Cerný A, Šestinová A, Zdenková A, Hill M, Dušková M, Procházka M, Vlk R, Kokrdová Z, Koucký M, Vitek L.

Ann Hepatol. 2016 Sep - Oct;15(5):757-761. doi: 10.5604/16652681.1212587.

22.

Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically!

Cerny A.

Swiss Med Wkly. 2015 Dec 23;145:w14231. doi: 10.4414/smw.2015.14231. eCollection 2015. No abstract available.

23.

The role of steroid hormones in the development of intrahepatic cholestasis of pregnancy.

Pařízek A, Dušková M, Vítek L, Šrámková M, Hill M, Adamcová K, Šimják P, Černý A, Kordová Z, Vráblíková H, Boudová B, Koucký M, Malíčková K, Stárka L.

Physiol Res. 2015;64 Suppl 2:S203-9. Review.

24.

[Update Chronic Viral Hepatitis B and C].

Terziroli Beretta-Piccoli B, Schranz M, De Gottardi A, Cerny A.

Praxis (Bern 1994). 2015 Dec 9;104(25):1393-7. doi: 10.1024/1661-8157/a002207. Review. German.

PMID:
26649957
25.

The GTP- and Phospholipid-Binding Protein TTD14 Regulates Trafficking of the TRPL Ion Channel in Drosophila Photoreceptor Cells.

Cerny AC, Altendorfer A, Schopf K, Baltner K, Maag N, Sehn E, Wolfrum U, Huber A.

PLoS Genet. 2015 Oct 28;11(10):e1005578. doi: 10.1371/journal.pgen.1005578. eCollection 2015 Oct.

26.

Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.

Terczyńska-Dyla E, Bibert S, Duong FHT, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Malinverni R, Mangia A, Moradpour D, Müllhaupt B, Negro F, Santoro R, Semela D, Semmo N; Swiss Hepatitis C Cohort Study Group, Heim MH, Bochud PY, Hartmann R.

Nat Commun. 2015 Jun 29;6:7280. doi: 10.1038/ncomms8280. No abstract available.

27.

Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.

Terczyńska-Dyla E, Bibert S, Duong FH, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Malinverni R, Mangia A, Moradpour D, Müllhaupt B, Negro F, Santoro R, Semela D, Semmo N; Swiss Hepatitis C Cohort Study Group, Heim MH, Bochud PY, Hartmann R.

Nat Commun. 2014 Dec 23;5:5699. doi: 10.1038/ncomms6699. Erratum in: Nat Commun. 2015;6:7280.

PMID:
25534433
28.

Survival of hepatocellular carcinoma patients is significantly improving: a population-based study from southern Switzerland.

Bordoni A, Cerny A, Bihl F, Alerci M, Mazzola P, Peverelli S, Marini G, Majno P, Mazzucchelli L, Spitale A.

Cancer Epidemiol. 2014 Dec;38(6):679-85. doi: 10.1016/j.canep.2014.09.008. Epub 2014 Oct 17.

PMID:
25454980
29.

Extinction retention and fear renewal in a lifetime obsessive-compulsive disorder sample.

McLaughlin NC, Strong D, Abrantes A, Garnaat S, Cerny A, O'Connell C, Fadok R, Spofford C, Rasmussen SA, Milad MR, Greenberg BD.

Behav Brain Res. 2015 Mar 1;280:72-7. doi: 10.1016/j.bbr.2014.11.011. Epub 2014 Nov 12.

30.

[Amniotic fluid embolism - review].

Cerný A, Pařízek A, Simják P.

Ceska Gynekol. 2014 Aug;79(4):255-9. Czech.

PMID:
25398145
31.

Impact of common risk factors of fibrosis progression in chronic hepatitis C.

Rüeger S, Bochud PY, Dufour JF, Müllhaupt B, Semela D, Heim MH, Moradpour D, Cerny A, Malinverni R, Booth DR, Suppiah V, George J, Argiro L, Halfon P, Bourlière M, Talal AH, Jacobson IM, Patin E, Nalpas B, Poynard T, Pol S, Abel L, Kutalik Z, Negro F.

Gut. 2015 Oct;64(10):1605-15. doi: 10.1136/gutjnl-2014-306997. Epub 2014 Sep 11.

PMID:
25214320
32.

Clinical significance of the CCR5delta32 allele in hepatitis C.

Morard I, Clément S, Calmy A, Mangia A, Cerny A, De Gottardi A, Gorgievski M, Heim M, Malinverni R, Moradpour D, Müllhaupt B, Semela D, Pascarella S, Bochud PY, Negro F; Swiss Hepatitis C Cohort Study Group.

PLoS One. 2014 Sep 5;9(9):e106424. doi: 10.1371/journal.pone.0106424. eCollection 2014.

33.

Fetal complications due to intrahepatic cholestasis of pregnancy.

Šimják P, Pařízek A, Vítek L, Černý A, Adamcová K, Koucký M, Hill M, Dušková M, Stárka L.

J Perinat Med. 2015 Mar;43(2):133-9. doi: 10.1515/jpm-2014-0089. Review.

PMID:
25153210
34.

Steroid metabolome in the umbilical cord: is it necessary to differentiate between arterial and venous blood?

Pašková A, Pařízek A, Hill M, Velíková M, Kubátová J, Dušková M, Adamcová K, Koucký M, Simjak P, Černý A, Stárka L.

Physiol Res. 2014;63(1):115-26. Epub 2013 Nov 1.

35.

Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients.

Frei P, Leucht AK, Held U, Kofmehl R, Manser CN, Schmitt J, Mertens J, Rau M, Baur K, Gerlach T, Negro F, Heim M, Moradpour D, Cerny A, Dufour JF, Müllhaupt B, Geier A; Swiss Hepatitis C Cohort Study Group.

Liver Int. 2014 Apr;34(4):551-7. doi: 10.1111/liv.12279. Epub 2013 Aug 29.

PMID:
24034338
36.

Neural systems underlying the influence of sound shape properties of the lexicon on spoken word production: do fMRI findings predict effects of lesions in aphasia?

Bullock-Rest N, Cerny A, Sweeney C, Palumbo C, Kurowski K, Blumstein SE.

Brain Lang. 2013 Aug;126(2):159-68. doi: 10.1016/j.bandl.2013.05.002. Epub 2013 Jun 4.

37.

Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection.

Fretz R, Negro F, Bruggmann P, Lavanchy D, De Gottardi A, Pache I, Masserey Spicher V, Cerny A.

Swiss Med Wkly. 2013 May 17;143:w13793. doi: 10.4414/smw.2013.13793. eCollection 2013. Review.

38.

Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development.

Lange CM, Miki D, Ochi H, Nischalke HD, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour JF, Gorgievski-Hrisoho M, Heim MH, Malinverni R, Müllhaupt B, Negro F, Semela D, Kutalik Z, Müller T, Spengler U, Berg T, Chayama K, Moradpour D, Bochud PY; Hiroshima Liver Study Group; Swiss Hepatitis C Cohort Study Group.

PLoS One. 2013 May 29;8(5):e64053. doi: 10.1371/journal.pone.0064053. Print 2013.

39.

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.

Bibert S, Roger T, Calandra T, Bochud M, Cerny A, Semmo N, Duong FH, Gerlach T, Malinverni R, Moradpour D, Negro F, Müllhaupt B, Bochud PY; Swiss Hepatitis C Cohort Study.

J Exp Med. 2013 Jun 3;210(6):1109-16. doi: 10.1084/jem.20130012. Epub 2013 May 27.

40.

Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.

Lange CM, Bibert S, Dufour JF, Cellerai C, Cerny A, Heim MH, Kaiser L, Malinverni R, Müllhaupt B, Negro F, Semela D, Moradpour D, Kutalik Z, Bochud PY; Swiss Hepatitis C Cohort Study Group.

J Hepatol. 2013 Sep;59(3):504-9. doi: 10.1016/j.jhep.2013.04.032. Epub 2013 May 9.

PMID:
23665287
41.

Mutation of light-dependent phosphorylation sites of the Drosophila transient receptor potential-like (TRPL) ion channel affects its subcellular localization and stability.

Cerny AC, Oberacker T, Pfannstiel J, Weigold S, Will C, Huber A.

J Biol Chem. 2013 May 31;288(22):15600-13. doi: 10.1074/jbc.M112.426981. Epub 2013 Apr 16.

42.

CD200R1 supports HSV-1 viral replication and licenses pro-inflammatory signaling functions of TLR2.

Soberman RJ, MacKay CR, Vaine CA, Ryan GB, Cerny AM, Thompson MR, Nikolic B, Primo V, Christmas P, Sheiffele P, Aronov L, Knipe DM, Kurt-Jones EA.

PLoS One. 2012;7(10):e47740. doi: 10.1371/journal.pone.0047740. Epub 2012 Oct 17.

43.

Methods for in vivo and in vitro analysis of innate immune responses to Helicobacter pylori infection.

Patel MK, Ryan GN, Cerny AM, Kurt-Jones EA.

Methods Mol Biol. 2012;921:209-25.

PMID:
23015507
44.

[New aspects in sonography of the liver].

Hagara D, Schwarzenbach HR, Cerny A.

Praxis (Bern 1994). 2012 Sep 5;101(18):1161-6. doi: 10.1024/1661-8157/a001063. Review. German.

PMID:
22945816
45.

Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.

Zhou S, Cerny AM, Fitzgerald KA, Kurt-Jones EA, Finberg RW.

J Virol. 2012 Oct;86(20):11254-65. Epub 2012 Aug 8.

46.

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma.

Kuske L, Mensen A, Müllhaupt B, Negro F, Semela D, Moradpour D, Malé PJ, Heim MH, Malinverni R, Cerny A, Dufour JF; Swiss Hepatitis C Cohort Study.

Swiss Med Wkly. 2012 Aug 6;142:w13651. doi: 10.4414/smw.2012.13651. eCollection 2012.

47.

Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.

Patin E, Kutalik Z, Guergnon J, Bibert S, Nalpas B, Jouanguy E, Munteanu M, Bousquet L, Argiro L, Halfon P, Boland A, Müllhaupt B, Semela D, Dufour JF, Heim MH, Moradpour D, Cerny A, Malinverni R, Hirsch H, Martinetti G, Suppiah V, Stewart G, Booth DR, George J, Casanova JL, Bréchot C, Rice CM, Talal AH, Jacobson IM, Bourlière M, Theodorou I, Poynard T, Negro F, Pol S, Bochud PY, Abel L; Swiss Hepatitis C Cohort Study Group, International Hepatitis C Genetics Consortium; French ANRS HC EP 26 Genoscan Study Group.

Gastroenterology. 2012 Nov;143(5):1244-1252.e12. doi: 10.1053/j.gastro.2012.07.097. Epub 2012 Jul 27.

48.

A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.

Lange CM, Bibert S, Kutalik Z, Burgisser P, Cerny A, Dufour JF, Geier A, Gerlach TJ, Heim MH, Malinverni R, Negro F, Regenass S, Badenhoop K, Bojunga J, Sarrazin C, Zeuzem S, Müller T, Berg T, Bochud PY, Moradpour D; Swiss Hepatitis C Cohort Study Group.

PLoS One. 2012;7(7):e40159. doi: 10.1371/journal.pone.0040159. Epub 2012 Jul 12.

49.

Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection.

Girardin F, Daali Y, Gex-Fabry M, Rebsamen M, Roux-Lombard P, Cerny A, Bihl F, Binek J, Moradpour D, Negro F, Desmeules J; Swiss Hepatitis C Cohort Study Group.

J Viral Hepat. 2012 Aug;19(8):568-73. doi: 10.1111/j.1365-2893.2011.01578.x. Epub 2012 Jan 26.

PMID:
22762141
50.

Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin.

Larrey D, Lohse AW, de Ledinghen V, Trepo C, Gerlach T, Zarski JP, Tran A, Mathurin P, Thimme R, Arastéh K, Trautwein C, Cerny A, Dikopoulos N, Schuchmann M, Heim MH, Gerken G, Stern JO, Wu K, Abdallah N, Girlich B, Scherer J, Berger F, Marquis M, Kukolj G, Böcher W, Steffgen J.

J Hepatol. 2012 Jul;57(1):39-46. doi: 10.1016/j.jhep.2012.02.015. Epub 2012 Mar 10.

PMID:
22414766

Supplemental Content

Support Center